Midazolam and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

Red cell distribution width increased is reported as a side effect among people who take Midazolam (midazolam), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Fentanyl, and have Sedation.

The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Midazolam. It is created by eHealthMe based on reports of 11,245 people who have side effects when taking Midazolam from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 604 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11,245 people reported to have side effects when taking Midazolam.
Among them, 24 people (0.21%) have Red cell distribution width increased.

Could Midazolam cause Red cell distribution width increased?

Among these 24 people:

How long have people been on Midazolam when they have Red cell distribution width increased? *

What is the gender of people who have Red cell distribution width increased when taking Midazolam? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Red cell distribution width increased when taking Midazolam? *

What are other drugs people take besides Midazolam? *

What are other side effects people have besides Red cell distribution width increased? *

C-Reactive Protein Increased: 14 people, 58.33%
Stress And Anxiety: 14 people, 58.33%
Iron Deficiency: 12 people, 50.00%
Weight Increased: 12 people, 50.00%
Nausea And Vomiting: 12 people, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 50.00%
Heart Rate Increased: 11 people, 45.83%
Fatigue (feeling of tiredness): 11 people, 45.83%
Platelet Count Increased: 10 people, 41.67%
Electrocardiogram Abnormal: 9 people, 37.50%

What are the existing conditions these people have? *

Sedation: 8 people, 33.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 29.17%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 7 people, 29.17%
Stress And Anxiety: 6 people, 25.00%
Insomnia (sleeplessness): 5 people, 20.83%
Colitis (inflammation of colon): 5 people, 20.83%
Constipation: 5 people, 20.83%
Pouchitis (inflammatory bowel disease): 2 people, 8.33%
Muscle Spasms (muscle contraction): 2 people, 8.33%
High Blood Cholesterol: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and have Red cell distribution width increased?

- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midazolam:

Midazolam (11,246 reports)

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Red cell distribution width increased:

Red cell distribution width increased (604 drugs)

Browse all the conditions that are associated with Red cell distribution width increased:

Red cell distribution width increased (656 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on midazolam (the active ingredients of Midazolam) and Midazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.